The illicit trade in hair loss treatments is surging in Switzerland, with nearly one in five seized medications now falling into this category. This represents a significant shift, as potency drugs previously dominated the illegal pharmaceutical market. Authorities are warning of increasing health risks associated with these unregulated products, as the source of these medications is also changing, with a growing proportion originating from Western Europe.
The rise in demand for hair loss remedies is particularly noticeable among younger adults. Swiss authorities report that individuals under 25 are increasingly turning to tinctures and shampoos promising hair growth, despite limited evidence of their effectiveness. Online retailer Galaxus has seen a threefold increase in sales of these products over the past three years, mirroring the trend observed in illegal imports. This growing demand is fueling a more sophisticated and geographically diverse illicit market.
In 2025, Swiss customs and border security (BAZG) intercepted 6,647 illegal shipments of pharmaceuticals, a 17 percent increase compared to the previous year, according to Swissmedic. While the overall number of seizures remains relatively stable, the composition of these shipments is changing dramatically. Hair loss treatments now account for approximately 19 percent of all seized medications, a stark contrast to previous years when erectile dysfunction drugs were the most commonly intercepted items, now representing 41 percent of seizures.
A Shift in Geographic Origin
Traditionally, illegal pharmaceuticals entering Switzerland originated from countries like India and Eastern Europe. However, Swissmedic reports a significant shift, with 40 percent of intercepted shipments now coming from Western European nations – a substantial increase from the 9 percent recorded in 2022. France and Germany are identified as key sources of these illicit products. This change suggests a more organized and accessible supply chain within Europe.
A concerning aspect of this trend is the proliferation of websites masquerading as legitimate Swiss online pharmacies. These sites often use Swiss flags, “.ch” domain names, and other deceptive tactics to create a false sense of security, despite lacking the necessary authorization to sell pharmaceuticals in Switzerland.
The Role of Criminal Intermediaries
An international operation conducted in November 2025 revealed the increasing sophistication of the illegal trade. Swissmedic, in collaboration with customs officials, Swiss Sport Integrity, and authorities in Liechtenstein, inspected 2,117 shipments. Over a quarter of these were seized. The operation uncovered a practice where criminal intermediaries break down large orders into smaller packages to stay below the threshold for personal import allowances. More than 200 such fragmented shipments were identified, and confiscated. Erectile dysfunction drugs originating from India, routed through EU countries via these intermediaries, were a particular concern.
Health Risks Associated with Illegal Medications
Swissmedic emphasizes the significant health risks associated with illegal pharmaceuticals. These products may contain incorrect dosages, contaminants, or even entirely different active ingredients than advertised. This can hinder recovery, cause adverse side effects, and, in the case of antibiotics or antiviral medications, contribute to the development of drug resistance. The potential for harm is particularly acute with counterfeit or substandard medications.
The increasing availability of unregulated hair loss treatments raises specific concerns. While many of these products may not pose an immediate physical threat, they often lack scientific backing and can be a financial burden for consumers. The lack of quality control means there’s no guarantee of their safety or efficacy.
The Swiss authorities are actively working to combat the illegal trade in pharmaceuticals, but the evolving tactics of criminals and the increasing demand for unregulated products present ongoing challenges. Consumers are urged to exercise caution when purchasing medications online and to only obtain prescriptions from licensed healthcare professionals and fill them at authorized pharmacies.
Looking ahead, Swissmedic and BAZG will continue to collaborate with international partners to disrupt the supply chains of illegal pharmaceuticals and protect public health. The next scheduled update on import statistics and enforcement actions is expected in the spring of 2026. Consumers seeking information on safe medication practices can visit the Swissmedic website.
Have you been affected by the sale of illegal pharmaceuticals? Share your experiences and thoughts in the comments below.
